GB0421911D0 - Methods and means - Google Patents

Methods and means

Info

Publication number
GB0421911D0
GB0421911D0 GBGB0421911.9A GB0421911A GB0421911D0 GB 0421911 D0 GB0421911 D0 GB 0421911D0 GB 0421911 A GB0421911 A GB 0421911A GB 0421911 D0 GB0421911 D0 GB 0421911D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0421911.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Original Assignee
Cambridge University Technical Services Ltd CUTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS filed Critical Cambridge University Technical Services Ltd CUTS
Priority to GBGB0421911.9A priority Critical patent/GB0421911D0/en
Publication of GB0421911D0 publication Critical patent/GB0421911D0/en
Priority to PCT/GB2005/003745 priority patent/WO2006037958A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0421911.9A 2004-10-01 2004-10-01 Methods and means Ceased GB0421911D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0421911.9A GB0421911D0 (en) 2004-10-01 2004-10-01 Methods and means
PCT/GB2005/003745 WO2006037958A2 (en) 2004-10-01 2005-09-29 Treatment of helminth infection by inhibition of tyrosinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0421911.9A GB0421911D0 (en) 2004-10-01 2004-10-01 Methods and means

Publications (1)

Publication Number Publication Date
GB0421911D0 true GB0421911D0 (en) 2004-11-03

Family

ID=33427958

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0421911.9A Ceased GB0421911D0 (en) 2004-10-01 2004-10-01 Methods and means

Country Status (2)

Country Link
GB (1) GB0421911D0 (en)
WO (1) WO2006037958A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817954B8 (en) * 2008-08-14 2021-05-25 Univ Federal Para use of 5-hydroxy-2-hydroxymethyl-y-pyrone as a macrophage activating agent to combat cutaneous leishmaniasis
KR101802911B1 (en) 2015-11-10 2017-11-30 전남대학교산학협력단 Composition for controlling root knot nematode comprising kojic acid as effective component and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303659A (en) * 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
JP3128780B2 (en) * 1992-02-04 2001-01-29 三省製薬株式会社 Tyrosinase activity inhibitor
US6077513A (en) * 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)
WO2003022855A1 (en) * 2001-09-07 2003-03-20 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Tert-butoxy dihydro artimisinin, its production and pharmaceutical composition
US6800615B2 (en) * 2002-04-15 2004-10-05 Board Of Trustees Of Michigan State University Antihelminthic anthraquinones and method of use thereof
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
FR2870122A1 (en) * 2004-05-14 2005-11-18 Galderma Res & Dev PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING MEQUINOL AND AT LEAST ONE DEPIGMENTING AGENT

Also Published As

Publication number Publication date
WO2006037958A2 (en) 2006-04-13
WO2006037958A3 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
GB0822148D0 (en) Methods and apparatus
EP1819226A4 (en) Immunostimulatory combinations and methods
HK1101911A1 (en) Tetrahydrocarbozoles and derivatives
IL179497A0 (en) Carboranylporphyrins and uses thereof
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1737565A4 (en) Cos-claus configurations and methods
IL184062A0 (en) Visco-supplement composition and methods
IL180365A0 (en) Carboranylporphyrins and uses thereof
EP1804703A4 (en) Cryo-surgical apparatus and methods
SG119251A1 (en) Methods
GB0412475D0 (en) Device and method
GB0424552D0 (en) Methods and means
GB0407382D0 (en) Therapeutic methods and means
GB0403847D0 (en) Methods and means
GB0426903D0 (en) Complexes and methods
GB0403629D0 (en) Methods
GB0407976D0 (en) Device and method
GB0407985D0 (en) Device and method
ZA200706038B (en) Visco-supplement composition and methods
GB0423552D0 (en) Methods
EP1938123A4 (en) Up-armoring structure and method
GB0421911D0 (en) Methods and means
GB0407968D0 (en) Device and method
GB0427483D0 (en) Methods and means
GB0419181D0 (en) Methods and means

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)